Scinovex
review Open AccessTop 1% cited

Posterior reversible encephalopathy syndrome

Journal of Neurology · 2017 · Vol. 264(8) · pp. 1608–1616
Marlene FischerErich Schmutzhard

Abstract

The posterior reversible encephalopathy syndrome (PRES) is a neurological disorder of (sub)acute onset characterized by varied neurological symptoms, which may include headache, impaired visual acuity or visual field deficits, disorders of consciousness, confusion, seizures, and focal neurological deficits. In a majority of patients the clinical presentation includes elevated arterial blood pressure up to hypertensive emergencies. Neuroimaging, in particular magnetic resonance imaging, frequently shows a distinctive parieto-occipital pattern with a symmetric distribution of changes reflecting vasogenic edema. PRES frequently develops in the context of cytotoxic medication, (pre)eclampsia, sepsis, renal disease or autoimmune disorders. The treatment is symptomatic and is determined by the underlying condition. The overall prognosis is favorable, since clinical symptoms as well as imaging lesions are reversible in most patients. However, neurological sequelae including long-term epilepsy may persist in individual cases.

Neurological Complications and SyndromesMoyamoya disease diagnosis and treatmentPharmacological Effects and Toxicity StudiesMedicinePosterior reversible encephalopathy syndromeNeuroimagingContext (archaeology)Magnetic resonance imagingNeurologyEclampsiaNeuroradiologyEncephalopathyCortical blindness

MeSH terms

HumansPosterior Leukoencephalopathy Syndrome
Citations
499
FWCI
25.28
field-weighted impact
References
143
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Posterior reversible encephalopathy syndrome · Scinovex